OmniAb Inc.

Company Profile

OmniAb Inc. had its IPO on 2022-11-02 under the ticker symbol OABI.

The company operates in the Healthcare sector and Biotechnology industry. OmniAb Inc. has a staff strength of 95 employees.

Stock update

Shares of OmniAb Inc. opened at $5.3 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $5.19 - $5.36, and closed at $5.22.

This is a -1.51% slip from the previous day's closing price.

A total volume of 231,649 shares were traded at the close of the day’s session.

In the last one week, shares of OmniAb Inc. have slipped by -10.46%.

OmniAb Inc.'s Key Ratios

OmniAb Inc. has a market cap of $677.26 million, indicating a price to book ratio of 1.7986 and a price to sales ratio of 10.1978.

In the last 12-months OmniAb Inc.’s revenue was $66.12 million with a gross profit of $59.08 million and an EBITDA of $-14841000. The EBITDA ratio measures OmniAb Inc.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, OmniAb Inc.’s operating margin was -51.24% while its return on assets stood at -5.95% with a return of equity of -9.49%.

In Q2, OmniAb Inc.’s quarterly earnings growth was a positive 0% while revenue growth was a negative 3.5%.

OmniAb Inc.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.23 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into OmniAb Inc.’s profitability.

OmniAb Inc. stock is trading at a EV to sales ratio of 11.3297 and a EV to EBITDA ratio of -26.0264. Its price to sales ratio in the trailing 12-months stood at 10.1978.

OmniAb Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$405.24 million

Total Liabilities

$24.24 million

Operating Cash Flow

$7.78 million

Capital Expenditure

$813000

Dividend Payout Ratio

0%

OmniAb Inc. ended 2024 with $405.24 million in total assets and $0 in total liabilities. Its intangible assets were valued at $405.24 million while shareholder equity stood at $333.81 million.

OmniAb Inc. ended 2024 with $0 in deferred long-term liabilities, $24.24 million in other current liabilities, 12000.00 in common stock, $-9576000.00 in retained earnings and $83.98 million in goodwill. Its cash balance stood at $20.99 million and cash and short-term investments were $103.15 million. The company’s total short-term debt was $3,417,000 while long-term debt stood at $0.

OmniAb Inc.’s total current assets stands at $115.94 million while long-term investments were $0 and short-term investments were $82.16 million. Its net receivables were $8.61 million compared to accounts payable of $2.36 million and inventory worth $0.

In 2024, OmniAb Inc.'s operating cash flow was $7.78 million while its capital expenditure stood at $813000.

Comparatively, OmniAb Inc. paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$5.22

52-Week High

$8.1

52-Week Low

$1.91

Analyst Target Price

$10.13

OmniAb Inc. stock is currently trading at $5.22 per share. It touched a 52-week high of $8.1 and a 52-week low of $8.1. Analysts tracking the stock have a 12-month average target price of $10.13.

Its 50-day moving average was $5.38 and 200-day moving average was $4.23 The short ratio stood at 7.82 indicating a short percent outstanding of 0%.

Around 409.4% of the company’s stock are held by insiders while 7407.6% are held by institutions.